Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device

Hemophilia A (HA) is a rare bleeding disorder caused by deficiency/dysfunction of the FVIII protein. As current therapies based on frequent FVIII infusions are not a definitive cure, long-term expression of FVIII in endothelial cells through lentiviral vector (LV)-mediated gene transfer holds the pr...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Cristina Olgasi, Chiara Borsotti, Simone Merlin, Thorsten Bergmann, Patrick Bittorf, Adeolu Badi Adewoye, Nicholas Wragg, Kelcey Patterson, Andrea Calabria, Fabrizio Benedicenti, Alessia Cucci, Alessandra Borchiellini, Berardino Pollio, Eugenio Montini, Delfina M. Mazzuca, Martin Zierau, Alexandra Stolzing, Philip.M. Toleikis, Joris Braspenning, Antonia Follenzi
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	hemophilia A cell and gene therapy medical device BOEC lentiviral vector FVIII Genetics QH426-470 Cytology QH573-671
Acceso en línea:	https://doaj.org/article/7a58ac952d7247cb827b394f9103e931
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device

Ejemplares similares